This study aims to provide a comprehensive assessment of GFAP and its relevance to several pathological or clinical measures in AD, illustrate the relevant but differential roles of various blood-based proteins, and clarify the influence of demographical variables on their concentrations independent of disease progression. This evidence concerns the gene GFAP and Alzheimer disease.